Clinical trials
Mucopolysaccharidosis III trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
58 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 3 |
| 2012 | 4 |
| 2013 | 4 |
| 2014 | 3 |
| 2015 | 4 |
| 2016 | 2 |
| 2017 | 4 |
| 2018 | 4 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 4 |
| 2024 | 4 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 24 |
| Terminated | 9 |
| Recruiting | 6 |
| Active, not recruiting | 6 |
| Unknown status | 5 |
| Not yet recruiting | 4 |
| Enrolling by invitation | 3 |
| Available | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shire | 6 |
| Alexion Pharmaceuticals, Inc. | 5 |
| Allievex Corporation | 5 |
| Ultragenyx Pharmaceutical Inc | 4 |
| LYSOGENE | 3 |
| Phoenix Nest | 3 |
| Abeona Therapeutics, Inc | 2 |
| JCR Pharmaceuticals Co., Ltd. | 2 |
| Masonic Cancer Center, University of Minnesota | 2 |
| Spruce Biosciences | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mucopolysaccharidosis III | 58 |
| Mucopolysaccharidoses | 12 |
| Lysosomal Storage Diseases | 9 |
| Mucopolysaccharidosis II | 8 |
| Leukodystrophy, Globoid Cell | 7 |
| Mucopolysaccharidosis I | 7 |
| Leukodystrophy, Metachromatic | 6 |
| Mucopolysaccharidosis VI | 6 |
| Genetic Diseases, Inborn | 5 |
| Metabolic Diseases | 5 |
Trials
Showing 1 to 25 of 58. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.